CME: Severe Uncontrolled Asthma: Assessing Phenotypic-driven Approaches to Treatment
- Published on Saturday, 29 December 2018 00:16
- Written by Juan Carlos Ivancevich
Released: December 18, 2018 Valid for credit through: December 17, 2019
An increasing body of evidence continues to define the presence of severe asthma subtypes that do not respond to standard therapies. While there are still no widely accepted definitions of phenotypes in severe asthma, guidelines from the European Respiratory Society and American Thoracic Society suggest that there may be certain characteristics, such as eosinophilic airway inflammation, that may guide health care professionals to tailor a more individualized, targeted treatment approach. In this live satellite symposium, experts in the field will evaluate asthma phenotypes and their implications for the treatment of severe uncontrolled asthma, as well as assess pertinent clinical studies utilizing monoclonal antibodies that target key immunologic mediators in severe asthma. The program will also feature the Wheel of Knowledge, a gaming segment that will reinforce topics discussed in the preceding didactic presentations.
Estimated Time To Complete: 60 minutes
By clicking "Continue to Activity" you attest that you have read and understood the CME required elements.